Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 30 ... for a variety of procedures. The company's initial focus is access for administering chemotherapy drugs and for conducting kidney dialysis. Grand Adler's first product, Rhapsody, which ...
Subject: Ben Franklin Technology Partners of Northeastern Pennsylvania BFTP/NEP
2009 NOV 30 ... may be a viable choice for patients with operable esophageal cancer who are undergoing chemotherapy and radiation treatment in preparation for surgery." Patients with ...
2009 NOV 30 ... cell samples delineates significantly superior overall survival for patients undergoing high-dose chemotherapy independent of conventional prognostic factors (International Staging System (ISS) ...
2009 NOV 30 ... of a study to test the anti-tumor effects of AEOL 10150 when combined with radiation and chemotherapy in nude mice bearing human non-small cell lung cancer (NSCLC) xenografts. This study, ...
2009 NOV 30 ... nervous system involvement was treated with craniospinal irradiation and intrathecal chemotherapy. Cutaneous involvement of MM is an unusual clinical presentation, but a high level of ...
2009 NOV 30 ... and symptomatology for intramedullary spinal cord tumors. One hundred fifty-eight chemotherapy and 183 radiation therapy articles for intramedullary spinal cord tumors were reviewed. ...
2009 NOV 30 ... journals. During the past two decades, chemoradiotherapy-combining chemotherapy and radiation treatments-has become important in helping preserve organs while treating ...
2009 NOV 30 ... of other organs were scheduled for heart transplantation. Four to 6 months later, high-dose melphalan chemotherapy and autologous stem cell transplantation (HDM-ASCT) was planned ...
2009 NOV 30 ... rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy (R-CHOP)," researchers in Vancouver, Canada report. "Using a Vysis ...
2009 NOV 30 ... Anticancer Therapy, Antiproliferative Activity, Apoptosis, Biotechnology, Cancer, Chemotherapy, Drug Development, Drug Resistance, Drug Therapy, Enzymes, Kinase, Life Sciences, ...
2009 NOV 30 ... and MN1 expression levels in a cohort of 210 patients with CN-AML who received intensive chemotherapy. Expression levels of ERG, BAALC, and MN1 were determined in bone marrow samples by ...
2009 NOV 30 ... report. "Multiple hepatic metastases were also found, and combination chemotherapy with irinotecan and S-1 was administered. Four months after the initiation of ...
2009 NOV 30 ... clinical benefit of antithrombotic prophylaxis in patients with cancer who are receiving chemotherapy, since these patients are at an increased risk of developing a thromboembolism. We did a ...
2009 NOV 30 ... untreated patients with PMLBCL were treated with a combination of a third-generation chemotherapy regimen (MACOP-B or VACOP-B), concurrent rituximab, and mediastinal radiation therapy. ...
2009 NOV 30 ... display high levels of soluble MICA in circulation, which could be downregulated by chemotherapy. The present study shows that anti-HCC drugs suppress MICA ectodomain shedding by ...
2009 NOV 30 ... among women treated for breast cancer, as well as those who did not receive adjuvant chemotherapy," researchers in the United States report. "Patients were assigned to ...
2009 NOV 30 ... of China, "The aim of the current study was to compare pharmacokinetics of local chemotherapy by pelvic intraarterial administration with intravenous injection in dogs. A total of 18 ...
2009 NOV 30 ... 5 patients; 3 were converted by a second resection, and 1 responded to augmentation of chemotherapy. Late death occurred for 2 patients without evidence of relapse. Among 54 survivors, 53 ...
2009 NOV 30 ... of this study was the evaluation of the feasibility and outcome of definitive radio-chemotherapy without split-course technique but with individualised short treatment interruption in ...
2009 NOV 23 ... "Besides conventional surgery, radiation therapy, and chemotherapy, which all tend to have side-effects and damage normal tissues, new medical strategies, ...
